Department Highlights
- Currently, faculty is receiving more than $23 million in funding from the National Institutes of Health primarily from the National Eye Institute (NEI)
- 10 NEI grants have been awarded to our 6 basic science faculty
- Our basic science faculty participate in multidisciplinary research underway in a number of Einstein's centers
- Our new office of clinical trials is designed to set up and perform a wide-range of ophthalmology clinical trials
- Beginning in 2011, the department is supported by the Research to Prevent Blindness Unrestricted Grant
The Department of Ophthalmology and Visual Sciences at Albert Einstein College of Medicine and Montefiore Medical Center strives to be among the leading vision care, research and educational centers in the U.S. To achieve this goal, the department provides and supports:
- Educational programs in ophthalmology for residents and fellows, medical students, ophthalmologists-in-residence, and health care professionals.
- Basic, clinical and translational research on diseases of the eye and the visual system
- A full range of eye care, including complex surgical procedures and transplantations
- Public education focused on prevention of eye disease and injury
- Community service to address disparities with access to health care.
In The Media
Epithelial Cells Use Immune Proteins to Find and Remove Precancerous Cells
(Sunday, Apr 17, 2022)
Why Do Some Smokers Never Get Lung Cancer?
Simon Spivack, M.D., M.P.H., and Jan Vijg, Ph.D., explain their study that suggests some smokers don't develop lung cancer because they have strong natural protection against cancer-causing mutations in lung cells. Dr. Spivack is professor of medicine, of epidemiology & population health, and of genetics at Einstein, and a pulmonologist at Montefiore Health System. Dr. Vijg is professor and chair of genetics, professor of ophthalmology and visual sciences, and the Lola and Saul Kramer Chair in Molecular Genetics at Einstein.
Additional coverage includes UPI, Medical News Today, Genome Web
(Wednesday, Apr 13, 2022)
coverage on other stories
